Copper in the tumor microenvironment and tumor metastasis

Area of Science:

• Biochemistry
• Molecular Biology
• Oncology

Background:

• Copper (Cu) is vital for cell proliferation and angiogenesis but its dysregulation causes oxidative stress and inflammation.
• Tumor tissues often show significant copper accumulation, impacting tumor progression.
• Copper homeostasis is regulated by transporters (e.g., CTR1, ATP7A/B) and chaperones (e.g., CCS, Atox-1).

Purpose of the Study:

• To review the role of copper transporters, chaperones, and copper-containing secretory enzymes in tumor progression.
• To elucidate the molecular mechanisms of copper's role in tumor metastasis.
• To understand how copper disturbances in tumor tissues contribute to cancer development.

Main Methods:

• Literature review of studies on copper metabolism in cancer.
• Analysis of the function of copper transporters and chaperones in tumor cells.
• Examination of the role of copper-dependent enzymes (SOD3, LOX) in metastasis.

Main Results:

• Abnormalities in copper transporters and chaperones lead to intracellular copper accumulation, promoting tumor progression.
• Dysfunctional copper-containing secretory enzymes like SOD3 and LOX are implicated in tumor metastasis.
• Loss of SOD3 promotes oxidative stress, neovascularization, and epithelial-to-mesenchymal transition (EMT).
• LOX activity contributes to the formation of the metastatic niche through collagen crosslinking.

Conclusions:

• Copper dysregulation is a significant factor in tumor progression and metastasis.
• Targeting copper regulation presents a potential novel strategy for inhibiting tumor metastasis.
• Further research is needed to fully understand the molecular mechanisms of copper's role in secretory enzymes and tumor development.